Dr. Jack West is joined by Dr. Alexander Drilon to discuss the challenge of NGS testing and increased participation and funding in lung cancer clinical trials. Dr. Drilon is Associate Attending Physician and Clinical Director of the Early Drug Development Service at Memorial Sloan Kettering Cancer Center in New York. Dr. Drilon has been at the forefront of development of many novel targeted therapies for some of the newest biomarker-driven therapies for advanced non-small cell.

NGS Testing & Participation And Funding In Clinical Trials with Dr. Alexander Drilon

Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 6,500 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit www.iaslc.org for more information.

Lung Cancer considered is funded in part by AstraZeneca, Daiichi Sankyo, Inc., and Takeda

Science

Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 6,500 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit www.iaslc.org for more information. Lung Cancer considered is funded in part by AstraZeneca, Daiichi Sankyo, Inc., and Takeda

Share NGS Testing & Participation And Funding In Clinical Trials with Dr. Alexander Drilon

Sign up to save your podcasts

NGS Testing & Participation And Funding In Clinical Trials with Dr. Alexander Drilon

NGS Testing & Participation And Funding In Clinical Trials with Dr. Alexander Drilon

More shows like Lung Cancer Considered

Freakonomics Radio

NEJM This Week

JAMA Clinical Reviews

Hidden Brain

The NPR Politics Podcast

ASCO Daily News

The Curbsiders Internal Medicine Podcast

Core IM | Internal Medicine Podcast

The Peter Attia Drive

Harrison's PodClass: Internal Medicine Cases and Board Prep

The Curious Clinicians

People I (Mostly) Admire

Conversations in Lung Cancer Research

The Weekly Show with Jon Stewart

Two Onc Docs